Treasury Shares Capital Expenditures Earnings Per Share, Dividends and Equity  Attributable to Owners of the Parent Per Share Data Policy on Shareholder Returns Stock Split ROE and DOE Common Stock Astellas makes capital expenditures on an ongoing basis  with the aim of reinforcing its capabilities and efficiency in  R&D and production, its capabilities in sales and marketing,  and its operational efficiency. Capital expenditures in fiscal  2013 totaled ¥25.7 billion, down 19.9% year on year  (based on the value of property, plant and equipment). In fiscal 2014, capital expenditures are forecast to  increase 28.4% to ¥33.0 billion. The Company cancelled 25,000 thousand treasury  shares* 1  on May 30, 2014. The Company acquired own shares worth ¥30.0 billion  (23,310 thousand shares* 1 ) from May 13, 2014 to June 23,  2014. Return on equity (ROE) was 7.4%, down 0.6 of a percent- age point from fiscal 2012. The DOE ratio was 5.0%, down  0.2 of a percentage point from fiscal 2012. * The Company conducted a stock split of common stock at a ratio of 5 to 1 with  an effective date of April 1, 2014. Earnings per share and equity per share  attributable to owners of the parent are calculated based on the number of shares  issued after the stock split (excluding treasury shares) on the assumption that the  stock split was conducted at the beginning of the year ended March 2013. Astellas is working to boost shareholder returns through  sustained growth in enterprise value. While prioritizing the  re-investment of funds in the business to foster growth,  Astellas strives to achieve stable and sustained growth in  dividends, based on medium to long-term consolidated  earnings growth and taking the dividend on equity attribut- able to owners of the parent (DOE) ratio into consideration.  Furthermore, Astellas will flexibly purchase treasury stock  as necessary to improve capital efficiency and the level of  return to shareholders. Total number of issued shares before stock split:  456,964,635 shares Increase in number of shares by stock split:  1,827,858,540 shares Total number of issued shares after stock split: 2,284,823,175 shares Total number of authorized shares after stock split: 9,000,000,000 shares Financial Section *1 The Company conducted a stock split of common stock at a ratio of 5 for 1  with an effective date of April 1, 2014. Figures for common stock and treasury  stock are calculated based on the number of shares issued after the stock  split (excluding treasury shares) on the assumption that the stock split was  conducted at the beginning of fiscal 2012. *2 Excludes purchases of shares constituting less than a trading unit (¥) 2013.3 2014.3 Earnings per share* Basic ¥ 40.27 ¥ 40.45 Diluted 40.21 40.39 Dividends 130.00 135.00 Equity per share attributable to  owners of the parent* 520.69 568.53 (thousands of shares) 2013.3 2014.3 Total number of issued shares* 1 2,339,823 2,284,823 Treasury shares* 1 83,942 53,681 Annual Report 2014 _  Astellas Pharma Inc.  101 2013.3 2014.3 Number of shares bought back* 1, 2 54,000  thousand 25,180  thousand Acquisition cost* 2 ¥49.4 billion ¥30.0 billion Cancellation of treasury shares* 1 55,000  thousand The Company conducted a stock split of common stock at  a ratio of 5 for 1 with an effective date of April 1, 2014. The purpose is to expand the Company’s investor base  and enhance the liquidity of its stock by reducing the price  per unit of shares to provide investors with more affordable  purchase opportunities. The stock split had a record date of March 31, 2014 and  involved the splitting of common stock owned by share- holders entered or recorded in the last register of share- holders as of the record date at a ratio of 5 for 1. (Increase in number of shares by stock split) (Purpose of stock split) (Method of stock split)